CRISPR-Cas9 Knock-out of SHP-1/2 to Reduce T cell Exhaustion in Adoptive Cell Therapy

摘要

The present invention includes compositions and methods comprising CART cells with SHP-1 and/or SHP-2 genes knocked out.